Abstract |
In this work, 23 new amides (14-36) bearing a representative diterpenoid structure unit, the functionalized bicyclo[3.2.1]octane ring, have been synthesized and its antitumor potential is studied. In vitro studies demonstrate that a number of amides with the bicyclo[3.2.1]oct-3-en-2-one subunit are active against HL-60, SMMC-7721, A-549, SK-BR-3, and PANC-1 tumor cell lines. The hybrid derivative, compound 20, was found to be the most potent compound (IC(50)=1.05 microM against HL-60) and more active than cisplatin (DDP), the positive control. Additionally, compound 20 exhibited broad spectrum in vitro anticancer activity with IC(50) values of 1.1-4.3 microM against the five tested cancer cell lines.
|
Authors | Zewei Mao, Yan Li, Jingbo Chen, Yuanyuan Wang, Hongbin Zhang |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 20
Issue 14
Pg. 4116-9
(Jul 15 2010)
ISSN: 1464-3405 [Electronic] England |
PMID | 20621726
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | 2010 Elsevier Ltd. All rights reserved. |
Chemical References |
- Bridged Bicyclo Compounds
- Diterpenes
|
Topics |
- Bridged Bicyclo Compounds
(chemistry)
- Carbohydrate Conformation
- Cell Line, Tumor
- Diterpenes
(chemical synthesis, chemistry, pharmacology)
- Humans
|